Advertisement

Accuracy of home pregnancy tests at the time of missed menses

      Abstract

      Objective

      The purpose of this study was to investigate the validity of home pregnancy tests (HPTs) around the time of the missed menses.

      Study design

      Levels of human chorionic gonadotropin (hCG) were determined in urine around the time of the missed menses, and 5th and 95th centiles were calculated. In a blind study evaluating 18 brands of HPTs, each was tested six times with five concentrations of hCG, 0 to 100 mIU/mL. Sensitivity was defined as the concentration at which six of six brands gave positive results, at the suggested reading time or at an extended time.

      Results

      It was estimated that a sensitivity of 12.5 mIU/mL was needed to detect 95% of pregnancies at the time of missing menses. Only 1 of 18 HPTs had this sensitivity. If faintly discernible results considered, 2 of 18 brands gave false-positive or invalid results. Clear positive results were given by only 44% of the brands at 100 mIU/mL hCG. If one accepted faintly discernible and extended reading times, all brands responded at 100 mIU/mL. A test with 100 mIU/mL sensitivity would detect approximately 16% of pregnancies at the time of missed menses.

      Conclusion

      The utility of HPTs is questioned. Clinicians need to be aware of the limitations of current HPT brands.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ventura S.J.
        • Mosher W.D.
        • Curtin S.C.
        • Abma J.C.
        • Henshaw S.
        Highlights of trends in pregnancies and pregnancy rates by outcome: estimates for the United States 1976-1996.
        Natl Vital Stat Rep. 1999; 47: 1-9
        • Butler S.A.
        • Khanlian S.A.
        • Cole L.A.
        Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices.
        Clin Chem. 2001; 47: 2131-2136
        • Cole L.A.
        • Isozaki T.
        • Jones E.E.
        Urine β-core fragment, a potential screening test for ectopic pregnancy and spontaneous abortion.
        Fetal Diagn Ther. 1997; 12: 336-339
        • Cole L.A.
        • Shahabi S.
        • Oz U.A.
        • Bahado-Singh R.O.
        • Mahoney M.J.
        Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening.
        Clin Chem. 1999; 45: 2109-2119
        • Wilcox A.J.
        • Weinberg C.R.
        • O'Connor J.F.
        • Baird D.D.
        • Schlatterer J.P.
        • Canfield R.E.
        • et al.
        Incidence of early loss of pregnancy.
        N Engl J Med. 1988; 319: 189-194
        • O'Connor J.F.
        • Ellish N.
        • Kakuma T.
        • Schlatterer J.
        • Kovalevskaya G.
        Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss.
        Prenat Diagn. 1998; 18: 1232-1240
        • Bjercke S.
        • Tanbo T.
        • Dale P.O.
        • Morkrid L.
        • Abyholm T.
        Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization.
        Hum Reprod. 1999; 14: 1642-1646
        • Wilcox A.J.
        • Baird D.D.
        • Dunson D.
        • McChesney R.
        • Weinberg C.R.
        Natural limits of pregnancy testing in relation to the expected menstrual period.
        JAMA. 2001; 286: 1759-1761
        • Cole L.A.
        • Khanlian S.A.
        • Sutton J.M.
        • Davies S.
        • Stephens N.
        Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection.
        Clin Biochem. 2003; 36: 647-655